284 related articles for article (PubMed ID: 28460880)
1. Transdifferentiation and reprogramming: Overview of the processes, their similarities and differences.
Cieślar-Pobuda A; Knoflach V; Ringh MV; Stark J; Likus W; Siemianowicz K; Ghavami S; Hudecki A; Green JL; Łos MJ
Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1359-1369. PubMed ID: 28460880
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming of retinoblastoma cancer cells into cancer stem cells.
Yue F; Hirashima K; Tomotsune D; Takizawa-Shirasawa S; Yokoyama T; Sasaki K
Biochem Biophys Res Commun; 2017 Jan; 482(4):549-555. PubMed ID: 27856246
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming and carcinogenesis--parallels and distinctions.
Wasik AM; Grabarek J; Pantovic A; Cieślar-Pobuda A; Asgari HR; Bundgaard-Nielsen C; Rafat M; Dixon IM; Ghavami S; Łos MJ
Int Rev Cell Mol Biol; 2014; 308():167-203. PubMed ID: 24411172
[TBL] [Abstract][Full Text] [Related]
4. Trib2 regulates the pluripotency of embryonic stem cells and enhances reprogramming efficiency.
Do EK; Park JK; Cheon HC; Kwon YW; Heo SC; Choi EJ; Seo JK; Jang IH; Lee SC; Kim JH
Exp Mol Med; 2017 Nov; 49(11):e401. PubMed ID: 29170476
[TBL] [Abstract][Full Text] [Related]
5. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine.
Xie M; Tang S; Li K; Ding S
Acc Chem Res; 2017 May; 50(5):1202-1211. PubMed ID: 28453285
[TBL] [Abstract][Full Text] [Related]
7. Derivation of Transgene-Free Rat Induced Pluripotent Stem Cells Approximating the Quality of Embryonic Stem Cells.
Li S; Lan H; Men H; Wu Y; Li N; Capecchi MR; Bryda EC; Wu S
Stem Cells Transl Med; 2017 Feb; 6(2):340-351. PubMed ID: 28191784
[TBL] [Abstract][Full Text] [Related]
8. A decade of transcription factor-mediated reprogramming to pluripotency.
Takahashi K; Yamanaka S
Nat Rev Mol Cell Biol; 2016 Mar; 17(3):183-93. PubMed ID: 26883003
[TBL] [Abstract][Full Text] [Related]
9. [Reprogramming of somatic cells. Problems and solutions].
Schneider TA; Fishman VS; Liskovykh MA; Ponamartsev SV; Serov OL; Tomilin AN; Alenina N
Tsitologiia; 2014; 56(12):869-80. PubMed ID: 25929128
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA Regulation Along the Course of Cellular Reprogramming to Pluripotency.
Ishtiaq M; Waseem M; Mehmood R
Curr Mol Med; 2018; 18(1):58-64. PubMed ID: 29663886
[TBL] [Abstract][Full Text] [Related]
11. A simpler twist of fate.
Eisenstein M
Nature; 2016 Jun; 534(7607):421-3. PubMed ID: 27306187
[No Abstract] [Full Text] [Related]
12. Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors.
Maza I; Caspi I; Zviran A; Chomsky E; Rais Y; Viukov S; Geula S; Buenrostro JD; Weinberger L; Krupalnik V; Hanna S; Zerbib M; Dutton JR; Greenleaf WJ; Massarwa R; Novershtern N; Hanna JH
Nat Biotechnol; 2015 Jul; 33(7):769-74. PubMed ID: 26098448
[TBL] [Abstract][Full Text] [Related]
13. Reduction of Fibrosis and Scar Formation by Partial Reprogramming In Vivo.
Doeser MC; Schöler HR; Wu G
Stem Cells; 2018 Aug; 36(8):1216-1225. PubMed ID: 29761584
[TBL] [Abstract][Full Text] [Related]
14. Enhanced generation of human induced pluripotent stem cells by ectopic expression of Connexin 45.
Ke Q; Li L; Yao X; Lai X; Cai B; Chen H; Chen R; Zhai Z; Huang L; Li K; Hu A; Mao FF; Xiang AP; Tao L; Li W
Sci Rep; 2017 Mar; 7(1):458. PubMed ID: 28352086
[TBL] [Abstract][Full Text] [Related]
15. Chick derived induced pluripotent stem cells by the poly-cistronic transposon with enhanced transcriptional activity.
Katayama M; Hirayama T; Tani T; Nishimori K; Onuma M; Fukuda T
J Cell Physiol; 2018 Feb; 233(2):990-1004. PubMed ID: 28387938
[TBL] [Abstract][Full Text] [Related]
16. Emerging methods for preparing iPS cells.
Miyazaki S; Yamamoto H; Miyoshi N; Takahashi H; Suzuki Y; Haraguchi N; Ishii H; Doki Y; Mori M
Jpn J Clin Oncol; 2012 Sep; 42(9):773-9. PubMed ID: 22826352
[TBL] [Abstract][Full Text] [Related]
17. Very Rapid and Efficient Generation of Induced Pluripotent Stem Cells from Mouse Pre-B Cells.
Di Stefano B; Graf T
Methods Mol Biol; 2016; 1357():45-56. PubMed ID: 25410286
[TBL] [Abstract][Full Text] [Related]
18. Effect of small molecules on cell reprogramming.
Baranek M; Belter A; Naskręt-Barciszewska MZ; Stobiecki M; Markiewicz WT; Barciszewski J
Mol Biosyst; 2017 Jan; 13(2):277-313. PubMed ID: 27918060
[TBL] [Abstract][Full Text] [Related]
19. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
[TBL] [Abstract][Full Text] [Related]
20. High throughput sequencing identifies an imprinted gene, Grb10, associated with the pluripotency state in nuclear transfer embryonic stem cells.
Li H; Gao S; Huang H; Liu W; Huang H; Liu X; Gao Y; Le R; Kou X; Zhao Y; Kou Z; Li J; Wang H; Zhang Y; Wang H; Cai T; Sun Q; Gao S; Han Z
Oncotarget; 2017 Jul; 8(29):47344-47355. PubMed ID: 28476045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
